Company
Sanifit
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Sanifit is a clinical-stage biopharmaceutical company focused on the development of SNF472, an experimental drug for the treatment of cardiovascular diseases linked to calcification in the end-stage renal disease population undergoing haemodialysis.
Loading relationship preview